Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Pediatr ; 19(11): 1182-6, 2012 Nov.
Article in French | MEDLINE | ID: mdl-23037580

ABSTRACT

In developed countries, Hansen disease, or leprosy, is a rare and little-known disease. Over the last few years, its prevalence in New Caledonia has remained stable (0.35 per 10,000 inhabitants). We report the case of an 11-year-old child who presented lepromatous leprosy complicated by a type 2 reaction. Despite appropriate treatment, the course was unusual with fever lasting a few weeks associated with asthenia, weight loss, and biological perturbations such as inflammatory syndrome, anemia, and hyperferritinemia. After a brief review of Hansen disease and its complications, we discuss the different hypotheses that can explain the clinical and biological progression of our patient (hemolytic anemia secondary to dapsone, type 2 reaction, and aspects of hemophagocytic syndrome) and describe therapeutic management, which led to a good outcome.


Subject(s)
Erythema Nodosum/diagnosis , Leprosy, Lepromatous/diagnosis , Anemia, Hemolytic/chemically induced , Child , Dapsone/adverse effects , Dapsone/therapeutic use , Disease Progression , Drug Therapy, Combination , Erythema Nodosum/drug therapy , Female , Hemoglobinometry , Humans , Leprostatic Agents/adverse effects , Leprostatic Agents/therapeutic use , Leprosy, Lepromatous/drug therapy , Lymphohistiocytosis, Hemophagocytic/diagnosis , New Caledonia , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...